It's an effort to compete with drugstore chains and pharmacy startups.
The plan would empower the Department of Health and Human Services to negotiate lower prices.
The answer comes down to one key tactic: negotiation.
President Trump expected to address the summit Wednesday.
The idea is that transparency would lead to more competition and lower costs. One drug company is already on board.
Contaminated supply chains, natural disasters, and the bottom line are just some of the reasons why basic drugs are in constant shortage.
President Trump is expected to call for an end to HIV transmission by 2030. The drug known as PrEP may be key.
Drug companies can get creative with doctor incentives, and that can be problematic.
Across the country, hospitals and clinics are dealing with a really difficult problem: Sometimes they can’t get their hands on certain life-saving generic drugs. So one group of large hospital systems, including the Mayo Clinic and Intermountain Healthcare, has come up with a workaround. It’s created a nonprofit company called Civica RX that will make […]
Pfizer hopes to run with its “little blue pill” as long as it can. That includes the time-honored strategy of launching its own generic.